Flow chart describing assessment for eligibility, enrollment, allocation, outcome and analysis of cats with chronic kidney disease for the maropitant study, which was a placebo-controlled, blinded clinical trial. *Medication was discontinued as the owner could no longer successfully administer it. †Subsequently discovered to be the other cat in the household that was vomiting